unitedhealth stock - Search News

Order byBest matchMost fresh

UnitedHealth, Medicare and Criminal Investigation

UnitedHealth Stock Falls. Selloff Deepens With Report of Medicare Fraud Investigation.

UnitedHealth Group stock fell early Thursday following a report that the Justice Department is investigating the company for possible criminal Medicare fraud.The news comes only days after the struggling health insurer announced the departure of its CEO Andrew Witty due to personal reasons and suspended its full-year guidance citing high medical costs in its insurance division.

· 26m · on MSN

· 26m

UnitedHealth’s troubles pile up, as stock sinks again after report of DOJ probe

· 7h · on MSN

UnitedHealth Group Is Under Criminal Investigation for Possible Medicare Fraud

UnitedHealth stock plummets

Digest more

UnitedHealth stock plummets after its CEO abruptly steps aside

UnitedHealth expected a return to growth next year amid Medicare Advantage cost pressures.

· 1d · on MSN

UnitedHealth Stock Tumbles on CEO Departure, Outlook Suspension

· 1d · on MSN

UnitedHealth CEO leaves abruptly, company pulls forecast as shares sink

UnitedHealth Group CEO steps down; suspends 2025 outlook on higher-than-expected medical costs

UnitedHealth CEO Andrew Witty is stepping down for personal reasons and the nation’s largest health insurer suspended its full-year financial outlook due to higher-than-expected medical costs.

· 2d

MedCity News · 1d

How Social Media Is Reacting to UnitedHealth Group’s CEO Exit and Stock Meltdown

· 1d

UnitedHealthcare CEO steps down as stock and earnings tank

UnitedHealth’s troubles get worse, as 2025 outlook suspended and CEO steps down

The withdrawal of the 2025 outlook comes less than a month after the company slashed its outlook, saying costs rose as Medicare Advantage care activity had increased at twice the expected rate.

· 1d

Back As UnitedHealth CEO, Hemsley Says Issues Within ‘Capacity To Resolve’

· 1d

UnitedHealth Group shake-up: CEO steps down, guidance suspended

2hon MSN

US stock futures slide as tariff rally eases, UnitedHealth slips

U.S. stock index futures slipped on Thursday as a rally fueled by the U.S.-China tariff truce appeared to ease, while UnitedHealth fell after a report of a DoJ investigation into the health insurer.

14m

UnitedHealth stock falls on criminal probe, Mizuho sees risk of Dow removal

“Given recent price action of UNH shares, losing more than $300bn of its $600bn market-cap in just one month, we believe there is some risk that the name is removed from the Dow,” Mizuho analysts wrote in a note Thursday.

UnitedHealth shares dive again, CoreWeave disappoints, and other early market movers

UnitedHealth shares are down about 5% after the Wall Street Journal reported the health insurer was under investigation by the Justice Department for fraud. The stock tu

15h

UnitedHealth Group: Capitulation After A 50% Plunge, I Am A Buyer

UnitedHealth Group's stock has plunged nearly 50% due to the CEO resignation, withdrawal of guidance, and ongoing legal issues, creating a potential buying opportunity. The stock is deeply oversold with an RSI of 15, trading below both the 200-day and 50-day moving averages, indicating capitulation.

Explore more

What’s Next For UNH Stock After Its Recent 50% Fall?

UnitedHealth (NYSE:UNH) stock looks attractive - making it a good pick to buy at its current price of around $320.

From titan to target: is UnitedHealth Group breaking down?

UnitedHealth Group's stock has collapsed nearly 50% in 2025 after a leadership shake-up, surging medical costs, and a DOJ criminal probe into Medicare fraud.

17hon MSN

UnitedHealth sees a longtime bull throw in the towel after stock’s plunge

An analyst reluctantly downgraded UnitedHealth’s stock, as the price plunge and a suspended full-year outlook was just too much to hold a bullish stance.

21h

UnitedHealth Group stock recovers Wednesday despite raft of Wall Street downgrades

UnitedHealth Group (UNH) stock opened more than 2.5% higher on Wednesday following the previous session's staggering loss of 17.8%. The fallout from the largest private health insurer in the US suspending its guidance as it deals with higher than expected medical costs has sent shivers down the spines of institutional shareholders.